Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells
Clinical trial NCT01495572 · TERMINATED
Trial details
- NCT number
- NCT01495572
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2014-02-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.